Vulnerability in Dexma Dexgate
CVE-2023-41088
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
EPSS: 0.002 (15.4th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 6.3 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N.
Affected products
- Dexma Dexgate — versions 20130114, version 20130114
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory)
Frequently asked questions
- What is CVE-2023-41088?
- CVE-2023-41088 is a medium-severity vulnerability in Dexma Dexgate, classified under Cleartext Transmission of Sensitive Information. CVSS score: 6.3/10. Published 2023-10-19.
- How severe is CVE-2023-41088?
- Medium severity. CVSS v3 base score is 6.3 out of 10.